U.S. market Closed. Opens in 4 hours 46 minutes

SMMT | Summit Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312019-01-312018-01-312017-01-312016-01-312015-01-312014-01-312013-01-312012-01-312011-01-312010-01-312009-01-312008-01-312007-01-312006-01-312005-01-312004-01-31
RevenueN/A704.29K1.81M860.00K632.02K56.41M35.98M2.88MN/A2.27M2.27M2.87M2.77M1.21M301.94K266.64K6.03M2.03M947.89K212.76K1.82K
Cost of Revenue2.05M2.51MN/AN/A155.40K24.92K97.67KN/AN/AN/AN/AN/A1.01MN/AN/A5.76K2.51M596.30K415.93K169.46K1.82K
Gross Profit-2.05M-1.81M1.81M860.00K476.62K56.39M35.88M2.88MN/A2.27M2.27M2.87M1.76M1.21M301.94K260.87K3.51M1.43M531.96K43.30KN/A
Operating Expenses87.69M64.28M88.00M53.19M42.00M47.69M54.13M33.94M29.45M19.29M13.33M8.51M7.45M5.55M9.49M15.43M26.92M10.03M3.74M579.92K43.79K
Selling, General & Admin28.21M26.70M23.61M19.23M9.30M16.19M16.98M10.35M7.45M6.80M3.24M2.77M2.31M2.68M4.20M5.03M7.31M1.86M1.79M75.31K43.79K
Research & Development59.47M52.00M85.35M53.27M32.71M51.38M41.01M23.69M23.94M15.64M10.83M5.72M4.78M3.66M3.68M7.38M15.34M5.79M1.83M504.60KN/A
Other Operating ExpensesN/A-14.42M-20.97M-19.31MN/A-19.88M-3.86M-1.95M-3.14M-682.90K-682.90K18.95K339.19K-10.32M3.48M2.97M2.70M2.37M119.60KN/A-1.82K
Operating Income-89.74M-72.09M-86.19M-53.19M-42.76M12.38M-18.25M-31.07M-28.73M-19.15M-11.07M-7.23M-4.71M-9.38M-9.20M-19.20M-23.40M-8.60M-3.21M-536.61K-43.79K
Other Expenses / Income-526.14M-19.15M-24.87M-14.01M-1.04M-3.30M1.91M-854.00K5.54M-427.00K14.85K17.37K6.28K20.57K-94.26K314.20K1.47M1.71M1.04M404.81K1.82K
Before Tax Income-615.87M-78.78M-88.60M-52.91M-28.41M6.60M-15.42M-32.13M-28.69M-19.07M-11.05M-7.21M-4.71M-9.36M-9.30M-18.88M-21.94M-6.88M-2.17M-131.80K-41.96K
Income Tax Expenses-946.00K-4.40M-2.46M-213.00K-4.52M-3.27M-5.32M-5.42M-4.36M-1.95M-1.00M-538.61K-477.37K-1.94M-594.31K-2.52M-1.81M-959.18K-278.48K-45.19K-1.82K
Net Income-614.93M-74.38M-86.15M-52.70M-23.88M9.87M-10.09M-26.71M-24.34M-17.12M-10.05M-6.67M-4.23M-7.42M-8.66M-32.29M-20.13M-5.92M-1.89M-86.61K-41.96K
Interest Expenses16.46M4.40M281.00K255.00K32.52K556.10K1.65M1.08MN/A448.00KN/AN/A4.71K6.33K107.04K116.74K75.56K11.77KN/AN/AN/A
Basic Shares Outstanding619.65M193.34M92.24M69.52M164.15M86.14M65.03M61.55M59.10M39.60M4.83M15.81M177.88M166.29M67.01M53.39M47.90M36.42M31.31M23.46M19.02M
Diluted Shares Outstanding619.65M193.34M92.24M69.52M164.15M86.14M65.43M61.55M59.10M39.60M4.83M15.81M177.88M166.29M67.01M53.39M47.90M36.42M31.31M23.46M19.02M
EBITDA1.00M-52.63M-62.74M-37.13M-16.80M11.65M-32.19M-30.98M-20.30M-12.20M-11.02M-5.48M-4.41M-8.65M-5.41M-16.03M-18.58M-6.13M-2.97M-527.20K-41.96K
EBITDA Margin0.00%-7,472.75%-3,467.99%-4,317.95%-2,657.39%20.66%-89.47%-1,075.82%0.00%-537.90%-486.04%-191.35%-159.04%-715.99%-1,790.48%-6,010.29%-308.42%-302.42%-313.56%-247.79%-2,300.00%
EBIT-599.41M-74.38M-88.32M-52.66M-28.38M7.15M-13.77M-31.06M-28.69M-18.63M-11.05M-7.21M-4.70M-9.36M-9.14M-34.69M-21.86M-6.87M-2.17M-131.80K-43.79K
EBIT Margin0.00%-10,561.06%-4,882.31%-6,122.67%-4,489.71%12.68%-38.27%-1,078.34%0.00%-821.26%-487.27%-251.71%-169.69%-774.84%-3,028.58%-13,010.31%-362.87%-338.78%-229.12%-61.95%-2,400.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312019-01-312018-01-312017-01-312016-01-312015-01-312014-01-312013-01-312012-01-312011-01-312010-01-312009-01-312008-01-312007-01-312006-01-312005-01-312004-01-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙